You just read:

Oncolytics Biotech® Announces Successful End-of-Phase 2 Meeting with FDA for REOLYSIN® in Metastatic Breast Cancer

News provided by

Oncolytics Biotech Inc.

Sep 18, 2017, 07:00 ET